SMTL ID : 4rwk.2 (1 other biounit)

Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.98 Å

Oligo State

monomer

Ligands

1 x 66T: N-{3-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-5-yl}-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide(Non-covalent)

66T.1: 17 residues within 4Å: Chain A: L.36, G.37, A.64, K.66, E.83, M.87, M.113, E.114, Y.115, A.116, S.117, K.118, G.119, L.182, A.192, D.193, F.194 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.36, A:A.64, A:L.182, A:A.192 Hydrogen bonds: A:A.116, A:A.116, A:A.116, A:D.193, A:D.193

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sohl, C.D. et al., Illuminating the Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance for the FGFR1 Gatekeeper Mutation: The Achilles' Heel of Targeted Therapy. Acs Chem.Biol. (2015)

Release Date

2015-04-15

Peptides

Fibroblast growth factor receptor 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Fibroblast growth factor receptor 1

Related Entries With Identical Sequence